Amgen
Trade Amgen 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About AMGN
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K.
AMGN Key Statistics
Stock Snapshot
Amgen(AMGN) stock is priced at $336.93, giving the company a market capitalization of 181.43B. It carries a P/E multiple of 26.71 and pays a dividend yield of 2.7%.
As of 2025-12-01, Amgen(AMGN) stock has fluctuated between $336.64 and $343.95. The current price stands at $336.93, placing the stock +0.1% above today's low and -2.0% off the high.
Amgen(AMGN) shares are trading with a volume of 1.34M, against a daily average of 2.87M.
In the last year, Amgen(AMGN) shares hit a 52-week high of $345.84 and a 52-week low of $253.30.
In the last year, Amgen(AMGN) shares hit a 52-week high of $345.84 and a 52-week low of $253.30.
AMGN News
Wondering if Amgen is a hidden gem or already fully priced? You’re not alone. Now might be the perfect time to take a closer look at its value. Amgen’s stock h...
Amgen (AMGN) just secured full approval from the FDA for IMDELLTRA, its new therapy for adults with advanced small cell lung cancer that has progressed after pl...
Amgen recently announced that the FDA granted full approval to IMDELLTRA (tarlatamab-dlle) for adults with extensive stage small cell lung cancer (ES-SCLC) whos...
Analyst ratings
45%
of 33 ratingsMore AMGN News
Tuesday, November 25, 2025 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research repor...
